The Black Death

Modern Plague Outbreaks

Plague has not been eradicated. Despite the development of effective antibiotics and the implementation of modern public health measures, Yersinia pestis continues to cause outbreaks in parts of the world where the bacterium remains endemic among wild rodent populations. The modern plague outbreaks of the twentieth and twenty-first centuries, while far smaller in scale than the Black Death, demonstrate that the disease remains a living threat and provide important lessons for understanding the pandemic’s historical impact.

The Global Distribution of Plague

The Third Pandemic, which began in the 1850s, established plague foci on every inhabited continent. Today, plague is endemic in parts of Madagascar, the Democratic Republic of Congo, Tanzania, Peru, Brazil, the United States (particularly the southwestern states), China, Mongolia, Vietnam, and India. The bacterium circulates among wild rodent populations — prairie dogs, ground squirrels, marmots, and gerbils — and is transmitted to humans through the bite of infected fleas.

The World Health Organization reports approximately 1,000 to 3,000 cases of plague annually, with the majority occurring in Madagascar, the Democratic Republic of Congo, and Peru. The actual number of cases may be higher, as many cases in rural areas go unreported.

The Madagascar Outbreak of 2017

The most significant recent plague outbreak occurred in Madagascar in 2017, when an epidemic of pneumonic plague killed more than 200 people and infected more than 2,000. The outbreak, which began in August 2017 and peaked in October, was notable for its urban focus — the majority of cases occurred in the capital city of Antananarivo — and for the predominance of pneumonic plague, which spreads directly between humans through respiratory droplets.

The outbreak required an international public health response coordinated by the World Health Organization. Contact tracing, prophylactic antibiotics, and infection control measures were implemented to contain the epidemic. The outbreak was eventually controlled, but it demonstrated the continued potential of plague to cause significant mortality in the absence of prompt diagnosis and treatment.

Plague in the United States

Plague has been endemic in the western United States since its introduction through the port of San Francisco in 1900. The bacterium circulates among wild rodent populations — particularly prairie dogs, ground squirrels, and rock squirrels — in the states of Arizona, Colorado, New Mexico, Utah, and California.

Approximately five to fifteen cases of plague are reported in the United States each year, typically among individuals who have been exposed to infected fleas while hiking, camping, or working outdoors. The mortality rate is low — approximately ten to fifteen percent — because diagnosis and treatment are generally prompt. However, delays in diagnosis can be fatal, and the disease remains a concern for public health officials in the affected states.

Antibiotic Resistance

One of the most concerning developments in modern plague is the emergence of antibiotic-resistant strains. In 1995, a strain of Y. pestis resistant to multiple antibiotics was isolated from a plague patient in Madagascar. The strain was resistant to streptomycin, tetracycline, chloramphenicol, and sulfonamides — the antibiotics most commonly used to treat plague.

While this particular strain did not spread widely, its emergence demonstrated the potential for antibiotic resistance to undermine the effectiveness of modern plague treatment. The continued monitoring of antibiotic susceptibility in plague strains is an important component of global plague surveillance.

Plague as a Bioweapon

Yersinia pestis is classified as a Category A bioterrorism agent by the Centers for Disease Control and Prevention, reflecting its potential to cause mass casualties if deliberately released as an aerosol. An aerosol release of Y. pestis would cause an outbreak of primary pneumonic plague, which is nearly always fatal without prompt antibiotic treatment and which spreads directly between humans.

The potential for plague to be used as a bioweapon has driven research into vaccines, rapid diagnostic tests, and new antibiotics. It has also informed the development of public health preparedness plans for responding to deliberate releases of the bacterium.

Lessons from Modern Plague

The study of modern plague outbreaks provides important lessons for understanding the historical impact of the Black Death. The continued existence of plague foci demonstrates that the bacterium is a persistent feature of the global environment, capable of causing catastrophic mortality when ecological and social conditions favour its spread. The effectiveness of antibiotics in reducing plague mortality demonstrates the transformative impact of medical science on a disease that was once the most feared in human history.